{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:11:42Z","timestamp":1792192302490,"version":"4.4.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,7,27]],"date-time":"2017-07-27T00:00:00Z","timestamp":1501113600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,7,27]],"date-time":"2017-07-27T00:00:00Z","timestamp":1501113600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Molecular data generation and their combination in penile carcinomas (PeCa), a significant public health problem in poor and underdeveloped countries, remain virtually unexplored. An integrativemethodology combin ing genome-wide copy number alteration, DNA methylation, miRNA and mRNA expression analysis was performed in a set of 20 usual PeCa. The well-ranked 16 driver candidates harboring genomic alterations and regulated by a set of miRNAs, including hsa-miR-31, hsa-miR-34a and hsa-miR-130b, were significantly associated with over-represented pathways in cancer, such as immune-inflammatory system, apoptosis and cell cycle. Modules of co-expressed genes generated from expression matrix were associated with driver candidates and classified according to the over-representation of passengers, thus suggesting an alteration of the pathway dynamics during the carcinogenesis. This association resulted in 10 top driver candidates (<jats:italic>AR, BIRC5, DNMT3B, ERBB4, FGFR1, PML, PPARG, RB1, TNFSF10<\/jats:italic> and <jats:italic>STAT1<\/jats:italic>) selected and confirmed as altered in an independent set of 33 PeCa samples. In addition to the potential driver genes herein described, shorter overall survival was associated with <jats:italic>BIRC5<\/jats:italic> and <jats:italic>DNMT3B<\/jats:italic> overexpression (log-rank test, P\u2009=\u20090.026 and P\u2009=\u20090.002, respectively) highlighting its potential as novel prognostic marker for penile cancer.<\/jats:p>","DOI":"10.1038\/s41598-017-06659-1","type":"journal-article","created":{"date-parts":[[2017,7,21]],"date-time":"2017-07-21T11:43:41Z","timestamp":1500637421000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Multidimensional integrative analysis uncovers driver candidates and biomarkers in penile carcinoma"],"prefix":"10.1038","volume":"7","author":[{"given":"Fabio Albuquerque","family":"Marchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Correa","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateus Camargo","family":"Barros-Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hellen","family":"Kuasne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariane Fidelis","family":"Busso Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Brentani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Carlos Souza","family":"Trindade Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo Cardoso","family":"Guimar\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliney F.","family":"Faria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristovam","family":"Scapulatempo-Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ademar","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia Regina","family":"Rogatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,27]]},"reference":[{"key":"6659_CR1","doi-asserted-by":"publisher","first-page":"9379","DOI":"10.1093\/nar\/gks725","volume":"40","author":"S Zhang","year":"2012","unstructured":"Zhang, S. et al. Discovery of multi-dimensional modules by integrative analysis of cancer genomic data. Nucleic Acids Res. \n                           40, 9379\u201391 (2012).","journal-title":"Nucleic Acids Res."},{"key":"6659_CR2","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1126\/science.1235122","volume":"29","author":"B Vogelstein","year":"2013","unstructured":"Vogelstein, B. et al. Cancer genome landscapes. Science. \n                           29, 1546\u201358 (2013).","journal-title":"Science."},{"key":"6659_CR3","doi-asserted-by":"publisher","first-page":"2910","DOI":"10.1073\/pnas.1213968110","volume":"110","author":"CD McFarland","year":"2013","unstructured":"McFarland, C. D., Korolev, K. S., Kryukov, G. V., Sunyaev, S. R. & Mirnya, L. A. Impact of deleterious passenger mutations on cancer progression. Proc Natl Acad Sci USA \n                           110, 2910\u20132915 (2013).","journal-title":"Proc Natl Acad Sci USA"},{"key":"6659_CR4","doi-asserted-by":"publisher","first-page":"e0162586","DOI":"10.1371\/journal.pone.0162586","volume":"11","author":"MA Budzinska","year":"2016","unstructured":"Budzinska, M. A. et al. Accumulation of Deleterious Passenger Mutations Is Associated with the Progression of Hepatocellular Carcinoma. PLoS ONE. \n                           11, e0162586 (2016).","journal-title":"PLoS ONE."},{"key":"6659_CR5","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/nrc3721","volume":"14","author":"VN Kristensen","year":"2014","unstructured":"Kristensen, V. N. et al. Principles and methods of integrative genomic analyses in cancer. Nat Rev Cancer. \n                           14, 299\u2013313 (2014).","journal-title":"Nat Rev Cancer."},{"key":"6659_CR6","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nrg3868","volume":"16","author":"MD Ritchie","year":"2015","unstructured":"Ritchie, M. D. et al. Methods of integrating data to uncover genotype-phenotype interactions. Nat Rev Genet. \n                           16, 85\u201397 (2015).","journal-title":"Nat Rev Genet."},{"key":"6659_CR7","doi-asserted-by":"publisher","first-page":"1001794","DOI":"10.1371\/journal.pmed.1001794","volume":"12","author":"AH Beck","year":"2015","unstructured":"Beck, A. H. Open access to large scale datasets is needed to translate knowledge of cancer heterogeneity into better patient outcomes. PLoS Med. \n                           12, 1001794 (2015).","journal-title":"PLoS Med."},{"key":"6659_CR8","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/ng1165","volume":"34","author":"E Segal","year":"2003","unstructured":"Segal, E. et al. Module networks: identifying regulatory modules and their condition-specific regulators from gene expression data. Nat Genet. \n                           34, 166\u201376 (2003).","journal-title":"Nat Genet."},{"key":"6659_CR9","doi-asserted-by":"publisher","first-page":"e1003983","DOI":"10.1371\/journal.pcbi.1003983","volume":"11","author":"E Bonnet","year":"2015","unstructured":"Bonnet, E., Calzone, L. & Michoel, T. Integrative multi-omics module network inference with Lemon-Tree. PLoS Comput Biol. \n                           11, e1003983 (2015).","journal-title":"PLoS Comput Biol."},{"key":"6659_CR10","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1186\/1471-2105-14-S16-S14","volume":"14","author":"PB Madhamshettiwar","year":"2013","unstructured":"Madhamshettiwar, P. B., Maetschke, S. R., Davis, M. J. & Ragan, M. A. RMaNI: Regulatory Module Network Inference framework. BMC Bioinformatics. \n                           14, S14 (2013).","journal-title":"BMC Bioinformatics."},{"key":"6659_CR11","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.urolonc.2006.08.029","volume":"25","author":"JS Barnholtz-Sloan","year":"2007","unstructured":"Barnholtz-Sloan, J. S., Maldonado, J. L., Pow-sang, J. & Giuliano, A. R. Incidence trends in primary malignant penile cancer. Urol Oncol. \n                           25, 361\u2013367 (2007).","journal-title":"Urol Oncol."},{"key":"6659_CR12","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.eururo.2014.10.017","volume":"67","author":"OW Hakenberg","year":"2015","unstructured":"Hakenberg, O. W. et al. EAU guidelines on penile cancer: 2014 update. Eur Urol. \n                           67, 142\u2013150 (2015).","journal-title":"Eur Urol."},{"key":"6659_CR13","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1590\/S1677-55382008000500007","volume":"34","author":"LA Favorito","year":"2008","unstructured":"Favorito, L. A. et al. Epidemiologic study on penile cancer in Brazil. Int Braz J Urol. \n                           34, 587\u201391 (2008).","journal-title":"Int Braz J Urol."},{"key":"6659_CR14","doi-asserted-by":"publisher","first-page":"10791","DOI":"10.3390\/ijms140610791","volume":"14","author":"H Kuasne","year":"2013","unstructured":"Kuasne, H., Marchi, F. A. & Rogatto, S. R. & de Syllos C\u00f3lus, I. M. Epigenetic mechanisms in penile carcinoma. Int J Mol Sci. \n                           14, 10791\u2013808 (2013).","journal-title":"Int J Mol Sci."},{"key":"6659_CR15","first-page":"1","volume":"90","author":"IARC","year":"2007","unstructured":"IARC. Human papillomaviruses. IARC Monogr Eval Carcinog Risks Hum. \n                           90, 1\u2013636 (2007).","journal-title":"IARC Monogr Eval Carcinog Risks Hum."},{"key":"6659_CR16","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.eururo.2015.12.007","volume":"69","author":"L Alemany","year":"2016","unstructured":"Alemany, L. et al. Role of Human Papillomavirus in Penile Carcinomas Worldwide. European Urology. \n                           69, 953\u2013961 (2016).","journal-title":"European Urology."},{"key":"6659_CR17","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1111\/iju.12759","volume":"22","author":"WH da Costa","year":"2015","unstructured":"da Costa, W. H. et al. Prognostic factors in patients with penile carcinoma and inguinal lymph node metastasis. Int J Urol. \n                           22, 669\u201373 (2015).","journal-title":"Int J Urol."},{"key":"6659_CR18","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1038\/bjc.2014.394","volume":"111","author":"PH Chiang","year":"2014","unstructured":"Chiang, P. H., Chen, C. H. & Shen, Y. C. Intraarterial chemotherapy as the first-line therapy in penile cancer. British Journal of Cancer. \n                           111, 1089\u20131094 (2014).","journal-title":"British Journal of Cancer."},{"key":"6659_CR19","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/nrurol.2016.54","volume":"13","author":"AL Burnett","year":"2016","unstructured":"Burnett, A. L. Penile preserving and reconstructive surgery in the management of penile cancer. Nat Rev Urol. \n                           13, 249\u201357 (2016).","journal-title":"Nat Rev Urol."},{"key":"6659_CR20","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s11912-011-0163-2","volume":"13","author":"GC Guimar\u00e3es","year":"2011","unstructured":"Guimar\u00e3es, G. C., Rocha, R. M., Zequi, S. C., Cunha, I. W. & Soares, F. A. Penile Cancer: Epidemiology and Treatment. Curr Oncol Rep. \n                           13, 231 (2011).","journal-title":"Curr Oncol Rep."},{"key":"6659_CR21","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13148-015-0082-4","volume":"7","author":"H Kuasne","year":"2015","unstructured":"Kuasne, H. et al. Genome-wide methylation and transcriptome analysis in penile carcinoma: uncovering new molecular markers. Clin Epigenetics. \n                           7, 46 (2015).","journal-title":"Clin Epigenetics."},{"key":"6659_CR22","doi-asserted-by":"crossref","unstructured":"Kuasne, H. et al. 2017. Integrative miRNA and mRNA analysis in penile carcinomas reveals markers and pathways with potential clinical impact. Oncotarget (2017).","DOI":"10.18632\/oncotarget.14783"},{"key":"6659_CR23","doi-asserted-by":"publisher","first-page":"5219","DOI":"10.1158\/0008-5472.CAN-15-1004","volume":"75","author":"AS McDaniel","year":"2015","unstructured":"McDaniel, A. S. et al. Genomic Profiling of Penile Squamous Cell Carcinoma Reveals New Opportunities for Targeted Therapy. Cancer Res. \n                           75, 5219\u201327 (2015).","journal-title":"Cancer Res."},{"key":"6659_CR24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1634\/theoncologist.2015-0241","volume":"21","author":"SM Ali","year":"2016","unstructured":"Ali, S. M. et al. Comprehensive Genomic Profiling of Advanced Penile Carcinoma Suggests a High Frequency of Clinically Relevant Genomic Alterations. Oncologist. \n                           21, 33\u20139 (2016).","journal-title":"Oncologist."},{"key":"6659_CR25","doi-asserted-by":"publisher","first-page":"4720","DOI":"10.1158\/0008-5472.CAN-15-3134","volume":"76","author":"A Feber","year":"2016","unstructured":"Feber, A. et al. CSN1 Somatic Mutations in Penile Squamous Cell Carcinoma. Cancer Res. \n                           76, 4720\u20137 (2016).","journal-title":"Cancer Res."},{"key":"6659_CR26","doi-asserted-by":"publisher","first-page":"24927","DOI":"10.1038\/srep24927","volume":"6","author":"W Zhang","year":"2016","unstructured":"Zhang, W., Edwards, A., Fang, Z., Flemington, E. K. & Zhang, K. Integrative Genomics and Transcriptomics Analysis Reveals Potential Mechanisms for Favorable Prognosis of Patients with HPV-Positive Head and Neck Carcinomas. Sci Rep. \n                           6, 24927 (2016).","journal-title":"Sci Rep."},{"key":"6659_CR27","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1093\/bioinformatics\/btm562","volume":"24","author":"A Joshi","year":"2008","unstructured":"Joshi, A., Van de Peer, Y. & Michoel, T. Analysis of a Gibbs sampler method for model-based clustering of gene expression data. Bioinformatics. \n                           24, 176\u201383 (2008).","journal-title":"Bioinformatics."},{"key":"6659_CR28","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/cgt.2016.5","volume":"23","author":"C Yang","year":"2016","unstructured":"Yang, C. et al. Integrative analysis of microRNA and mRNA expression profiles in non-small-cell lung cancer. Cancer Gene Ther. \n                           23, 90\u20137 (2016).","journal-title":"Cancer Gene Ther."},{"key":"6659_CR29","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1111\/j.1349-7006.2008.00870.x","volume":"99","author":"H Yamamoto","year":"2008","unstructured":"Yamamoto, H., Ngan, C. Y. & Monden, M. Cancer cells survive with survivin. Cancer Sci. \n                           99, 1709\u201314 (2008).","journal-title":"Cancer Sci."},{"key":"6659_CR30","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.3892\/ol.2016.4718","volume":"12","author":"MV Shepelev","year":"2016","unstructured":"Shepelev, M. V. et al. hTERT and BIRC5 gene promoters for cancer gene therapy: A comparative study. Oncol Lett. \n                           12, 1204\u20131210 (2016).","journal-title":"Oncol Lett."},{"key":"6659_CR31","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.jconrel.2016.04.018","volume":"240","author":"S Wang","year":"2016","unstructured":"Wang, S. et al. Nanoparticle-mediated inhibition of survivin to overcome drug resistance in cancer therapy. J Control Release. \n                           240, 454\u2013464 (2016).","journal-title":"J Control Release."},{"key":"6659_CR32","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1038\/oncsis.2016.33","volume":"5","author":"Y de Jong","year":"2016","unstructured":"de Jong, Y. et al. Targeting survivin as a potential new treatment for chondrosarcoma of bone. Oncogenesis. \n                           5, e22 (2016).","journal-title":"Oncogenesis."},{"key":"6659_CR33","doi-asserted-by":"publisher","first-page":"e0131336","DOI":"10.1371\/journal.pone.0131336","volume":"10","author":"L Zhang","year":"2015","unstructured":"Zhang, L. et al. MicroRNA Expression Profile in Penile Cancer Revealed by Next-Generation Small RNA Sequencing. PLoS ONE \n                           10, e0131336 (2015).","journal-title":"PLoS ONE"},{"key":"6659_CR34","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.juro.2016.01.115","volume":"196","author":"JM Hartz","year":"2016","unstructured":"Hartz, J. M. et al. Integrated Loss of miR-1\/miR-101\/miR-204 Discriminates Metastatic from Nonmetastatic Penile Carcinomas and Can Predict Patient Outcome. J Urol. \n                           196, 570\u20138 (2016).","journal-title":"J Urol."},{"key":"6659_CR35","doi-asserted-by":"publisher","first-page":"e1327","DOI":"10.1038\/cddis.2014.270","volume":"5","author":"XJ Li","year":"2014","unstructured":"Li, X. J., Ren, Z. J. & Tang, J. H. MicroRNA-34a: a potential therapeutic target in human cancer. Cell Death and Disease. \n                           5, e1327 (2014).","journal-title":"Cell Death and Disease."},{"key":"6659_CR36","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1158\/1078-0432.CCR-11-3225","volume":"18","author":"NN Khodarev","year":"2012","unstructured":"Khodarev, N. N., Roizman, B. & Weichselbaum, R. R. Molecular Pathways: Interferon\/Stat1 Pathway: Role in the Tumor Resistance to Genotoxic Stress and Aggressive Growth. Clin Can Res. \n                           18, 3015\u20133021 (2012).","journal-title":"Clin Can Res."},{"key":"6659_CR37","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.mrfmmm.2009.09.009","volume":"690","author":"H Martin","year":"2010","unstructured":"Martin, H. Role of PPAR-gamma in inflammation. Prospects for therapeutic intervention by food components. Mutat Res. \n                           690, 57\u201363 (2010).","journal-title":"Mutat Res."},{"key":"6659_CR38","doi-asserted-by":"publisher","first-page":"4129","DOI":"10.4049\/jimmunol.178.7.4129","volume":"178","author":"EA Wohlfert","year":"2007","unstructured":"Wohlfert, E. A., Nichols, F. C., Nevius, E. & Clark, R. B. Peroxisome proliferator-activated receptor gamma (PPARgamma) and immunoregulation: enhancement of regulatory T cells through PPARgamma-dependent and -independent mechanisms. J Immunol. \n                           178, 4129\u201335 (2007).","journal-title":"J Immunol."},{"key":"6659_CR39","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/j.eururo.2009.02.021","volume":"55","author":"C Protzel","year":"2009","unstructured":"Protzel, C. et al. Lymphadenectomy in the surgical management of penile cancer. Eur Urol. \n                           55, 1075\u201388 (2009).","journal-title":"Eur Urol."},{"key":"6659_CR40","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1093\/annonc\/mds635","volume":"24","author":"G Sonpavde","year":"2013","unstructured":"Sonpavde, G. et al. Penile cancer: current therapy and future directions. Ann Oncol. \n                           24, 1179\u20131189 (2013).","journal-title":"Ann Oncol."},{"key":"6659_CR41","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/j.1464-410X.2008.07697.x","volume":"102","author":"BK Kroon","year":"2008","unstructured":"Kroon, B. K. et al. Microarray gene-expression profiling to predict lymph node metastasis in penile carcinoma. BJU Int. \n                           102, 510\u20135 (2008).","journal-title":"BJU Int."},{"key":"6659_CR42","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1158\/1940-6207.CAPR-14-0284","volume":"8","author":"AF Busso-Lopes","year":"2015","unstructured":"Busso-Lopes, A. F. et al. Genomic profiling of human penile carcinoma predicts worse prognosis and survival. Cancer Prev Res. \n                           8, 149\u201356 (2015).","journal-title":"Cancer Prev Res."},{"key":"6659_CR43","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nm0897-917","volume":"3","author":"G Ambrosini","year":"1997","unstructured":"Ambrosini, G., Adida, C. & Altieri, D. C. A novel anti-apoptosis gene, Survivin, expressed in cancer and lymphoma. Nat Med. \n                           3, 917\u201321 (1997).","journal-title":"Nat Med."},{"key":"6659_CR44","first-page":"331","volume":"7","author":"I Porebska","year":"2010","unstructured":"Porebska, I., Soba\u0144ska, E., Kosacka, M. & Jankowska, R. Apoptotic regulators: P53 and survivin expression in non-small cell lung cancer. Cancer Genomics Proteomics. \n                           7, 331\u20135 (2010).","journal-title":"Cancer Genomics Proteomics."},{"key":"6659_CR45","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/1471-2407-13-82","volume":"13","author":"L Cao","year":"2013","unstructured":"Cao, L. et al. OCT4 increases BIRC5 and CCND1 expression and promotes cancer progression in hepatocellular carcinoma. BMC Cancer. \n                           13, 82 (2013).","journal-title":"BMC Cancer."},{"key":"6659_CR46","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1021\/bi001603q","volume":"40","author":"S Shin","year":"2001","unstructured":"Shin, S. et al. An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7. Biochemistry. \n                           40, 1117\u201323 (2001).","journal-title":"Biochemistry."},{"key":"6659_CR47","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.1038\/onc.2014.304","volume":"34","author":"SN Brun","year":"2015","unstructured":"Brun, S. N. et al. Survivin as a therapeutic target in Sonic hedgehog-driven medulloblastoma. Oncogene. \n                           34, 3770\u20139 (2015).","journal-title":"Oncogene."},{"key":"6659_CR48","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12935-016-0326-1","volume":"16","author":"H Garg","year":"2016","unstructured":"Garg, H., Suri, P., Gupta, J. C., Talwar, G. P. & Dubey, S. Survivin: a unique target for tumor therapy. Cancer Cell Int. \n                           16, 49 (2016).","journal-title":"Cancer Cell Int."},{"key":"6659_CR49","first-page":"819","volume":"23","author":"X Su","year":"2010","unstructured":"Su, X. et al. Expression pattern and clinical significance of DNA methyltransferase 3B variants in gastric carcinoma. Oncol Rep. \n                           23, 819\u2013826 (2010).","journal-title":"Oncol Rep."},{"key":"6659_CR50","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/onc.2013.580","volume":"34","author":"I Teneng","year":"2015","unstructured":"Teneng, I. et al. Global identification of genes targeted by DNMT3b for epigenetic silencing in lung cancer. Oncogene. \n                           34, 621\u201330 (2015).","journal-title":"Oncogene."},{"key":"6659_CR51","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1016\/j.humpath.2013.07.002","volume":"44","author":"X Zhang","year":"2013","unstructured":"Zhang, X. et al. Down-regulation of miR-145 and miR-143 might be associated with DNA methyltransferase 3B overexpression and worse prognosis in endometrioid carcinomas. Hum Pathol. \n                           44, 2571\u201380 (2013).","journal-title":"Hum Pathol."},{"key":"6659_CR52","doi-asserted-by":"publisher","first-page":"e89956","DOI":"10.1371\/journal.pone.0089956","volume":"9","author":"WC Chen","year":"2014","unstructured":"Chen, W. C., Chen, M. F. & Lin, P. Y. Significance of DNMT3b in Oral Cancer. PLoS ONE \n                           9, e89956 (2014).","journal-title":"PLoS ONE"},{"key":"6659_CR53","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. \n                           43, e47 (2015).","journal-title":"Nucleic Acids Res."},{"key":"6659_CR54","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","volume":"29","author":"MW Pfaffl","year":"2001","unstructured":"Pfaffl, M. W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. \n                           29, e45 (2001).","journal-title":"Nucleic Acids Res."},{"key":"6659_CR55","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1186\/1471-2105-8-S2-S5","volume":"8","author":"T Michoel","year":"2007","unstructured":"Michoel, T. et al. Validating module networks learning algorithms using simulated data. BMC Bioinformatics. \n                           8, S5 (2007).","journal-title":"BMC Bioinformatics."},{"key":"6659_CR56","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.juro.2014.11.097","volume":"194","author":"JJ Mu\u00f1oz","year":"2015","unstructured":"Mu\u00f1oz, J. J. et al. Down-Regulation of SLC8A1 as a Putative Apoptosis Evasion Mechanism by Modulation of Calcium Levels in Penile Carcinoma. J Urol \n                           194, 245\u201351 (2015).","journal-title":"J Urol"},{"key":"6659_CR57","doi-asserted-by":"publisher","first-page":"R95","DOI":"10.1186\/gb-2007-8-5-r95","volume":"8","author":"KR Brown","year":"2007","unstructured":"Brown, K. R. & Jurisica, I. Unequal evolutionary conservation of human protein interactions in interologous networks. Genome Biol. \n                           8, R95 (2007).","journal-title":"Genome Biol."},{"key":"6659_CR58","doi-asserted-by":"publisher","first-page":"3327","DOI":"10.1093\/bioinformatics\/btp595","volume":"25","author":"KR Brown","year":"2009","unstructured":"Brown, K. R. et al. NAViGaTOR: Network Analysis, Visualization and Graphing Toronto. Bioinformatics. \n                           25, 3327\u20139 (2009).","journal-title":"Bioinformatics."},{"key":"6659_CR59","unstructured":"R Development Core Team. R: A language and environment for statistical computing. http:\/\/www.R-project.org (2016)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-06659-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-06659-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-06659-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T07:32:34Z","timestamp":1671780754000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-06659-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,27]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["6659"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-06659-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,27]]},"assertion":[{"value":"17 February 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"6707"}}